Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-02-25 @ 6:43 PM
Study NCT ID:
NCT05918133
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-11
First Post:
2023-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Sponsor:
Biotheus Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-15
First Submit QC Date:
None
Study First Post Date:
2023-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-09
Last Update Post Date:
2025-03-11
Last Update Post Date Type:
ACTUAL